The second part of a 3-part series of blogs on the “Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome” study looks at who was in the study and how they were selected, how severely the study was truncated by the pandemic (quite...
It took about three years but the first major international conference on long COVID – the “Keystone Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” conference recently took place in Santa Fe, New Mexico at the El...
The great question for chronic fatigue syndrome and long COVID is: what causes post-exertional malaise (PEM)? The latest study to come out of Nancy Klimas’s Institute for Neuroimmune Medicine – led by Lubov Nathanson (senior author) and directed by Derek...
Study suggests natural killer cells are whacking the small nerve fibers in fibromyalgia After decades of surveying chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) literature, the study, “Unbiased immune profiling reveals a natural killer cell-peripheral...
Eric Schadt, the study’s senior author, is not your average researcher, and Phillip Comella, the lead author, has personal experience with mysterious diseases and difficult diagnoses. A biomathematician and bioengineer, Schadt has been at the forefront of...
A recent Australian study suggested an already FDA approved drug can revive the not so killer natural killer cells found in ME/CFS in the lab. If that finding translates to humans we’ll have a breakthrough in the one verified immune hole in ME/CFS – one...